Pablo Botas is the CEO & scientific director of Foundation 29 of February, where he leads the development of tools for rare disease patients in order to accelerate diagnosis with www.dx29.ai and to better leverage their healthcare information through patient-owned registries for RWE generation with Health 29. With a PhD in physics, he has strong expertise in scientific computation and artificial intelligence, fields that he has applied to proton radiotherapy and rare disease prediction via phenotypic and variant analysis leveraging patient population knowledge.